MPC3100(958025-66-6)
- Name: MPC3100
- Synonyms:CS-215;MPC3100;(2S)-1-[4-[2-[6-amino-8-[(6-bromo-1,3-benzodioxol-5-yl)sulfanyl]purin-9-yl]ethyl]piperidin-1-yl]-2-hydroxypropan-1-one;(2S)-1-[4-[2-[6-Amino-8-[(6-bromo-1,3-benzodioxol-5-yl)thio]-9H-purin-9-yl]ethyl]-1-piperidinyl]-2-hydroxy-1-propanone
- Molecular Formula:C22H25BrN6O4S
- Molecular Weight:549.448
- CAS Registry Number:958025-66-6
- EINECS:200-258-5
- Melting Point:
- Water Solubility:
CAS No.958025-66-6 MPC3100
Assay:95% Application:Synthetic building block
Min. Order:0
Supplier:SAGECHEM LIMITED [
China (Mainland)] CAS No.958025-66-6 MPC-3100
Assay:95%+ or 98%+ Appearance:solid Package:10mg/25mg/50mg/100mg/1000mg/5000mg Storage:short-term storage normal temperature. long-term storage 2-8 鈩?nbsp;Application:for drug impurities, for drug standards,for drug research and development
Min. Order:0
Supplier:Hubei Moxin Biotechnology Co., Ltd [
China (Mainland)] CAS No.958025-66-6 MPC3100
Assay:99% Application:MPC3100
Min. Order:0
Supplier:weifang yangxu group co.,ltd [
China (Mainland)] CAS No.958025-66-6 MPC-3100 cas 958025-66-6
Assay:98% min Appearance:solid powder Package:Packing according to customer's requirements Storage:Keep containers tightly closed. Store in a cool, dry area away from incompatible substances. Transportation:Conventional transport Application:Pharmaceuticals
Min. Order:100Milligram
Supplier:Taizhou Crene Biotechnology co.ltd [
China (Mainland)] CAS No.958025-66-6 MPC-3100
Assay:>98% Appearance:Solid powder Package:inquiry Storage:Store at -20掳C Transportation:inquiry Application:MPC-3100 targets the N-terminal ATP-binding site of Hsp90 and blocks the activity of ATPase. In the Her2-luciferase degradation assay, MPC-3100 reduces this client protein of Hsp90 with IC50 value...
Min. Order:0
Supplier:BOC Sciences [
United States] - SAGECHEM LIMITED
Other Product
- 1219125-39-9/3-[(2R)-1-acetyl-2-pyrrolidinyl]--aMino-5-isoxazolepropanoic acid Methyl ester
- 1154667-75-0/1-(1-Methylethyl)-4-(4-piperidinylMethyl)-piperazine
- 31774-74-0/5-Chloro-2-(3-pyridinyl)-4,6(1H,5H)-pyrimidinedione
- 1015223-89-8/[5-(3-OxopropylaMino)thieno[3,2-b]pyridin-7-yl] benzoate hydrochloride
- 871709-90-9/1H-Indazole-3,6-diamine
- 1038393-19-9/IMidazo[1,2-a]pyridine-2-carboxylic acid, 8-broMo-, ethyl ester
- 1015070-53-7/N-Boc-3-Amino-4-phenylpyrrolidine
- 96946-55-3/Isoquinolinium, 2,2'-[1,5-pentanediylbis[oxy(3-oxo-3,1-propanediyl)]]bis[1-[(3,4-dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-, (1S,1'S,2S,2'S)-
- 1193104-79-8/[5-[3-[(1R,2R)-1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propanoyloxy]-3-methylpentyl] 3-[(1R,2R)-1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propanoate
- 732929-47-4/Isoquinolinium, 1-[(3,4-dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2,2-dimethyl-, (1R)-
- 1075726-97-4/Benzyl 3-[(1R,2S)-1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propanoate
- 150322-85-3/Ethanone, 1-(6,7-dihydro-2-nitrothieno[3,2-c]pyridin-5(4H)-yl)-
- 1294481-80-3/β-D-erythro-Pentofuranose, 2-deoxy-2-fluoro-2-methyl-, 3,5-bis(4-chlorobenzoate), (2R)-
- 790220-87-0/Cyclohexanol, 1-methyl-4-(1-methylethenyl)-2-(4-oxido-4-morpholinyl)-,
- 103324-02-3/3-Benzofuranol, 2,3-dihydro-2,2-dimethyl-
- 439084-30-7/Benzenepentanamide,N-[1-[3-[(3,4-dimethoxyphenyl)methyl]-2,5-dihydro-5-oxo-1,2,4-triazin-6-yl]ethyl]-α-(1-hydroxyethyl)-
- 710654-74-3/(R)-3-(4-propylmorpholin-2-yl)phenol
- 1149705-71-4/XL888
- 934343-74-5/NVP-HSP990(HSP990)
- 958025-66-6/MPC3100
- 1204531-24-7/RO-4987655
- 1256589-74-8/9-Ethyl-6,6-dimethyl-8-(4-morpholinopiperidin-1-yl)-11-oxo-5a,6,11,11a-tetrahydro-5H-benzo[b]carbazole-3-carbonitrile hydrochloride
- 957298-76-9/GSK-364735
- 947182-25-4/RO5068760
- 1163719-51-4/CCT239065
- 1197850-19-3/6-Fluoro-2-(4-fluorophenyl)imidazo[1,2-a]pyridine-3-carbaldehyde
- 1307233-93-7/hexyl aMino(4-aMinophenyl)MethylenecarbaMate hydrochloride
- 1103234-56-5/2,6-Difluoro-3-(propylsulfonaMido)benzoic acid
- 255706-13-9/Dabigatran Etexilate iMpurity I
- 1307233-94-8/Ethyl 3-(2-(chloromethyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate